Medical Information
Australia
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Australian Healthcare Professionals. Would you like to proceed?

I am a healthcare professionalYes, I am a healthcare professional
SelectI am a healthcare professionalYes, I am a healthcare professional
I am a patient / caregiverNo, go back to the patient portal
SelectI am a patient / caregiverNo, go back to the patient portal
Non-Australia residents click here.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

The Therapeutic Goods Administration (TGA) has granted Comirnaty® (tozinameran) COVID-19 Vaccine provisional approval for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 5 years of age and older. The use of this vaccine should be in accordance with official recommendations.

COMIRNATY®(tozinameran)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

COMIRNATY® Quick Finder

Did you find an answer to your question? Yes No
View (purple cap) product information

View [Tris/Sucrose Presentation](grey/orange cap) product information
View (purple cap) consumer medicine information
View [Tris/Sucrose Presentation](grey/orange cap) consumer medicine information
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Call 1 800 675 229*

*9AM-5PM (AEST) Monday to Friday

Connect with Pfizer Medical Information regarding your medical question.

Medical Enquiry
Submit a medical question for Pfizer prescription products.
Pfizer Safety
Pfizer Safety

Contact Pfizer Safety to report a suspected side effect or adverse event for COMIRNATY® vaccine.